Hormone treatment restores bone density for young women with menopause-like condition

June 10, 2014 by Katie Rush
Hormone treatment restores bone density for young women with menopause-like condition
Researchers at the NIH examined scans of the hip and lower spine to determine the effects of hormone treatment on bone mineral density of women with primary ovarian insufficiency.

Researchers have found that hormone replacement therapy in young women with primary ovarian insufficiency (POI) led to increases in their bone mineral density, restoring levels to normal. The study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health.

The findings provide important treatment information for women with POI and their physicians.

Spontaneous POI, which affects 1 in 100 women by age 40, occurs when the ovaries stop producing sufficient estrogen in the absence of a known cause, such as anorexia, chromosome abnormality, or chemotherapy. It is typically characterized by irregular or absent menstrual cycles, hot flashes, and fertility problems. Women with POI have abnormally low levels of reproductive hormones, including estradiol, a type of estrogen produced by the ovary, as well as testosterone, a predominantly male hormone, but also produced by women in smaller amounts. They also have reduced , which can lead to osteoporosis and

"Bone mineral density is an important measure of . This study showed that not only could hormone treatment reduce the rate at which women with POI lose bone mineral density, but it could actually restore to normal levels," said Dr. Lawrence M. Nelson, study author and investigator in the Program on Reproductive and Adult Endocrinology at NICHD.

The findings were published online in the Journal of Clinical Endocrinology & Metabolism.

Using bone density scans of the hip and lower spine, researchers measured the effects of two hormone replacement regimens on the bone mineral density of women with POI who were between the ages of 18 and 42. One hundred and forty-five women with POI were randomly assigned to one of two groups: one group received a 100 mcg estradiol patch, progestin pills, and a 150 mcg testosterone patch, and the other group received a 100 mcg estradiol patch, progestin pills, and a placebo patch. For comparison, the scientists also measured bone mineral density in an untreated group of 70 women with normal ovarian function.

Both hormone treatment regimens led to significant increases in the bone mineral density in the treatment groups. When the study began, women with POI had significantly lower hip and spine bone mineral density levels compared to the control group. By the study's end, both bone density measures had increased to the same levels as the women without the condition.

However, the addition of testosterone in the treatment regimen did not prove to be statistically significant in helping increase density. Further studies with a greater number of women would be needed to produce statistically valid results as to whether testosterone replacement could benefit women with POI, Dr. Nelson said.

"While 's effect on bone has been studied in postmenopausal women, there is limited research on the effects of this therapy in younger women," said lead author Dr. Vaishali B. Popat, an endocrinologist who helped conduct this study at NIH. "This study provides important evidence that hormone replacement therapy with an appropriate dose of estradiol delivered via a skin patch combined with oral progestin can improve bone density to normal in with ."

Explore further: Romosozumab increases bone mineral density post-menopause

Related Stories

Romosozumab increases bone mineral density post-menopause

January 6, 2014

(HealthDay)—Romosozumab seems safe and effective for increasing bone mineral density in postmenopausal women with low bone mineral density, according to a study published online Jan. 1 in the New England Journal of Medicine.

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.